The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Apr. 23, 2019
Filed:
Sep. 09, 2011
Applicants:
Yanmin HU, London, GB;
Anthony R M Coates, London, GB;
Inventors:
Yanmin Hu, London, GB;
Anthony R M Coates, London, GB;
Assignee:
HELPERBY THERAPEUTICS LIMITED, London, GB;
Attorney:
Primary Examiner:
Assistant Examiner:
Int. Cl.
CPC ...
A61K 31/10 (2006.01); A61K 31/145 (2006.01); A61K 31/05 (2006.01); A61K 31/18 (2006.01); A61K 38/12 (2006.01); A61K 33/24 (2019.01); A61K 38/14 (2006.01); A61K 45/06 (2006.01); A61K 31/138 (2006.01); A61K 31/167 (2006.01); A61K 31/216 (2006.01); A61K 31/282 (2006.01); A61K 31/305 (2006.01); A61K 31/382 (2006.01); A61K 31/395 (2006.01); A61K 31/407 (2006.01); A61K 31/417 (2006.01); A61K 31/445 (2006.01); A61K 31/473 (2006.01); A61K 31/475 (2006.01); A61K 31/517 (2006.01); A61K 31/4178 (2006.01); A61K 31/4709 (2006.01); A61K 31/4741 (2006.01); A61K 31/5415 (2006.01); A61K 31/704 (2006.01); A61K 31/7052 (2006.01);
U.S. Cl.
CPC ...
A61K 38/12 (2013.01); A61K 31/05 (2013.01); A61K 31/10 (2013.01); A61K 31/138 (2013.01); A61K 31/145 (2013.01); A61K 31/167 (2013.01); A61K 31/18 (2013.01); A61K 31/216 (2013.01); A61K 31/282 (2013.01); A61K 31/305 (2013.01); A61K 31/382 (2013.01); A61K 31/395 (2013.01); A61K 31/407 (2013.01); A61K 31/417 (2013.01); A61K 31/4178 (2013.01); A61K 31/445 (2013.01); A61K 31/473 (2013.01); A61K 31/475 (2013.01); A61K 31/4709 (2013.01); A61K 31/4741 (2013.01); A61K 31/517 (2013.01); A61K 31/5415 (2013.01); A61K 31/704 (2013.01); A61K 31/7052 (2013.01); A61K 33/24 (2013.01); A61K 38/14 (2013.01); A61K 45/06 (2013.01); Y02A 50/401 (2018.01); Y02A 50/404 (2018.01); Y02A 50/406 (2018.01); Y02A 50/469 (2018.01); Y02A 50/473 (2018.01); Y02A 50/475 (2018.01); Y02A 50/478 (2018.01); Y02A 50/479 (2018.01); Y02A 50/481 (2018.01); Y02A 50/483 (2018.01);
Abstract
The present invention relates to the use of one or more compounds selected from the following classes of biologically active agents: an a-adrenergic antagonist, an anthelmintic agent, an antifungal agent, an antimalarial agent, an antineoplastic agent, an antipsychotic agent, an antioxidant, a vasodilator and/or a vitamin, or a pharmaceutically acceptable derivative thereof, for use in the treatment of a microbial infection and in particular for killing multiplying, non-multiplying and/or clinically latent microorganisms associated with such an infection.